{"id":"W4400274003","doi":"10.1200/jco.2024.42.16_suppl.3082","title":"Final results of a first-in-human phase I dose escalation trial of daily oral zelenirstat, a n-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lymphomas.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Spinal Cord Injury BC; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Refractory (planetary science); Maximum tolerated dose; Solid tumor; Clinical trial; Cancer research; Pharmacology; Oncology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001931097,0.001559615,0.00190859,0.0003469856,0.000521309,0.0009329439,0.0008463415,0.00134941,0.004089823],"category_scores_gemma":[0.0008907677,0.0005391028,0.00131852,0.000326626,0.000681435,0.0009293694,0.0003697484,0.00333701,0.001161182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001121141,"about_ca_system_score_gemma":0.001381443,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009041082,"about_ca_topic_score_gemma":0.002587016,"domain_scores_codex":[0.999522,0.0001847118,0.00003086818,0.00009851552,0.00004684405,0.0001171123],"domain_scores_gemma":[0.9992372,0.0001021759,0.0001188654,0.00009038312,0.00007816667,0.0003733066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7249035,0.08061693,0.009362687,0.0008900165,0.002428946,0.0004356461,0.0003769045,0.005142076,0.07604343,0.0003634156,0.0113997,0.08803672],"study_design_scores_gemma":[0.4196212,0.5377375,0.02211379,0.00004263999,0.001067025,0.0005301951,0.00008774392,0.001645916,0.009361302,0.0004444905,0.007306495,0.00004167353],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9798495,0.001892099,0.001379816,0.0006615639,0.0001776343,0.0062203,0.006073524,0.0002027062,0.003542868],"genre_scores_gemma":[0.9755695,0.001100452,0.0030558,0.001209854,0.000101066,0.004648738,0.01050038,0.0000682438,0.003746066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004089823,"threshold_uncertainty_score":0.01368183,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03001202910532041,"score_gpt":0.3647388429982193,"score_spread":0.3347268138928989,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}